Businessman Virgilio Villar’s Medilines is optimistic about its prospects in the coming years given the government’s initiative to advance and expand medical facilities in the country.
Medilines said the current administration’s support to increase the accessibility to dialysis treatments by raising the number of dialysis centers across the country bodes well for the growth of its dialysis portfolio.
The company said it continues to rely on its dialysis consumables segment for growth in the coming years.
In addition, Medilines is also expected to benefit from the Health Facilities Enhancement Program’s plan to build specialty centers throughout different regions in the country.
The company said all of the highly specialized care that these centers offer such as renal care, lung care, cancer care, and cardiovascular care can be addressed by Medilines’ portfolio of medical devices.
“As long as our portfolio of medical devices continues to address and complement the most pressing healthcare needs of our country, we remain confident that Medilines’ business outlook stays positive,” Medilines president Patricia Yambing said.
In 2022, Medilines saw a 24 percent jump in revenues with sales reaching P1.96 billion, while core net income surged by 52 percent to P215 million.
